AIIMS recalls two syringe batches over quality concerns in a single month; probe sought
The Union Health Ministry has been urged to investigate the repeated recall of disposable syringe batches at the All-India Institute of Medical Sciences (AIIMS), New Delhi, and the possible implications for patient safety.In a letter written to Union Health Minister J.P. He added that the notices issued by the Hospital Stores, AIIMS, include the first recall notice dated May 5, 2026, which directed the return of Batch No. 10DSR243, manufactured by M/s Noble Pharmacare Limited under the brand name Edgex, within 48 hours.
- ▪The Union Health Ministry has been urged to investigate the repeated recall of disposable syringe batches at the All-India Institute of Medical Sciences (AIIMS), New Delhi, and the possible implications for patient safety.In a letter writte
- ▪He added that the notices issued by the Hospital Stores, AIIMS, include the first recall notice dated May 5, 2026, which directed the return of Batch No.
- ▪10DSR243, manufactured by M/s Noble Pharmacare Limited under the brand name Edgex, within 48 hours.
The Hindu publishes from India and files mainly under world. We currently carry 754 of its stories.
Opening excerpt (first ~120 words) tap to expand
The Union Health Ministry has been urged to investigate the repeated recall of disposable syringe batches at the All-India Institute of Medical Sciences (AIIMS), New Delhi, and the possible implications for patient safety.In a letter written to Union Health Minister J.P. Nadda, on Wednesday (June 10, 2026), Member of Rajya Sabha Haris Beeran said that in the past month, two separate recall notices were issued within a span of three weeks for disposable 10 ml syringes with needles supplied by different manufacturers, citing quality-related complaints.“The development has raised concerns over medical device safety and quality assurance protocols in premier healthcare institutions,’’ he said.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Hindu.
Discussion
0 commentsMore from The Hindu
